National Eye Institute. Statistics and Data. Available at: www.nei.nih. gov/eyedata. Accessed November 14, 2007.
The Eye Disease Prevalence Research Group. Cause and prevalence of visual impairment among adults in US. Arch Ophthlamol. 2004 Apr;122(4):477-85.
Hogg R, Chakravarthy U. Age-related macular degeneration and micronutrients antioxidants. Curr Eye Res. 2004 Dec;29(6):387-401.
Allen MJ, Jarding JB, Zehner. Macular degeneration treatment with nutrients and micro current electricity. J Orthomolec Med. 1998;13:211-14.
Seddon JM, Ajani UA, Sperduto R. Dietary carotenoids, vitamins A, C, and E, and advanced AMD: Eye disease case control study. JAMA. 1994 Nov 9;272(18):1413-20.
AREDS Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with Vitamin C and E, beta carotene, and zinc for AMD and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001 Oct;119(10):1417-36.
AREDS Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with Vitamin C and E, beta carotene, and zinc for AMD and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001 Oct;119(10):1439-52.
Clemons TE, Chew EY, Bressler SB, et al. Research group national eye institute visual function questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS report no. 10. Arch Ophthalmol. 2003 Feb;121(2):211-7.
Richer S, Stiles W, Statkute L. Double-masked, placebo-controlled, randomized trial of lutein and antioxidants supplementation in the intervention of atrophic AMD: Veterans LAST study. Optometry. 2004 Apr;75(4):216-30.
SanGiovanni JP, Chew EY, Clemons TE, et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No.
Arch Ophthalmol. 2007 Sep;125(9):1225-32.
SanGiovanni JP, Chew EW, Argon E, et al The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23.Arch Opthlamol. 2008 Sep;126(9):1274-9.
Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013 May 15:309(19):2005-15.
Smigel K. Beta carotene fails to prevent cancer in two major studies: CARET intervention stopped. J Natl Cancer Inst. 1996 Feb 21;88(3- 4):145.
The Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein/Zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report No. 4. JAMA Ophthalmol. 2013 May 5:1-7.
AREDS 2 Research Group. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology. 2012 Nov;119(11):2282-9.